globe life inc. - GL
GL
Close Chg Chg %
120.97 0.89 0.74%
Closed Market
121.86
+0.89 (0.74%)
Volume: 616.74K
Last Updated:
May 30, 2025, 3:59 PM EDT
Company Overview: globe life inc. - GL
GL Key Data
| Open $120.69 | Day Range 120.69 - 122.23 |
| 52 Week Range 76.55 - 133.76 | Market Cap $9.99B |
| Shares Outstanding 82.54M | Public Float 81.93M |
| Beta 0.56 | Rev. Per Employee N/A |
| P/E Ratio 9.84 | EPS $12.36 |
| Yield 81.84% | Dividend $0.27 |
| EX-DIVIDEND DATE Jul 3, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 670.98K |
GL Performance
| 1 Week | 2.06% | ||
| 1 Month | 0.03% | ||
| 3 Months | -4.36% | ||
| 1 Year | 47.11% | ||
| 5 Years | 58.23% |
GL Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
14
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 142.50 | |
| Number of Ratings | 14 | Current Quarters Estimate | 3.258 | |
| FY Report Date | 06 / 2025 | Current Year's Estimate | 13.694 | |
| Last Quarter’s Earnings | 3.07 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 12.37 | Next Fiscal Year Estimate | 14.927 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 11 | 11 | 12 | 12 |
| Mean Estimate | 3.26 | 3.87 | 13.69 | 14.93 |
| High Estimates | 3.37 | 4.08 | 13.95 | 15.15 |
| Low Estimate | 3.22 | 3.46 | 13.43 | 14.70 |
| Coefficient of Variance | 1.27 | 4.91 | 1.00 | 1.01 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 8 | 8 | 8 |
| OVERWEIGHT | 0 | 0 | 1 |
| HOLD | 6 | 6 | 5 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Globe Life Inc. - GL
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Globe Life Inc. - GL
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 21, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | 1,820 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $123.39 per share | 224,569.80 |
| Mar 21, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | 3,250 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 21, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | 7,368 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $121.75 per share | 897,054.00 |
| Mar 21, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | 3,040 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $126.41 per share | 384,286.40 |
| Mar 21, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | 6,000 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 21, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 21, 2025 | Michael Shane Henrie SVP & Chief Accounting Officer | 5,790 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $103.23 per share | 597,701.70 |
| Mar 6, 2025 | Robert E. Hensley EVP & Chief Investment Officer | 10,193 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $124.82 per share | 1,272,290.26 |
| Mar 6, 2025 | Matthew J. Adams Director | 1,183 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Philip M. Jacobs Director | 1,183 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Michael Clay Majors EVP - Chief Strategy Officer | 47,066 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Robert B. Mitchell EVP, General Counsel and CRO | 8,074 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Robert B. Mitchell EVP, General Counsel and CRO | 6,764 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $121.93 per share | 824,734.52 |
| Mar 3, 2025 | Robert B. Mitchell EVP, General Counsel and CRO | 9,519 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Michael Clay Majors EVP - Chief Strategy Officer | 12,800 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Michael Clay Majors EVP - Chief Strategy Officer | 45,681 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $121.93 per share | 5,569,884.33 |
| Mar 3, 2025 | Michael Clay Majors EVP - Chief Strategy Officer | 48,688 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Frank M. Svoboda Co-Chairman & CEO; Director | 50,471 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | James Matthew Darden Co-Chairman & CEO; Director | 50,818 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Frank M. Svoboda Co-Chairman & CEO; Director | 29,817 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |